Company: BIVIW
Filing Date: 2025-08-11
Form Type: 8-K
Source: 0001520138-25-000249
Chunk: 0

Company: BIOVIE INC.
Filing Date: 2025-08-11
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry Into a Material Definitive Agreement

On August 7, 2025, BioVie Inc. (the “ Company”) entered into an underwriting
agreement (the “ Underwriting Agreement”) with ThinkEquity LLC, as the sole underwriter (the “ Underwriter”),
in connection with the issuance and sale (the “ Offering”) of 5,620,000 units (the “Units”) and 380,000
pre-funded units (the “Pre-Funded Units”), resulting in net proceeds of approximately $10.4 million, after deducting
underwriting discounts and commissions and other estimated offering expenses. The Underwriter also exercised the Over-Allotment Option
(as defined below) in part and purchased 667,300 Warrants (as defined below) for nominal additional gross proceeds of approximately $667.

Each Unit consisted of (i) one share of common stock, par value $0.0001
(the “ Common Stock”), of the Company and (ii) one warrant (the “ Warrants”). Each Pre-Funded Unit
consisted of (i) one pre-funded warrant (the “Pre-Funded Warrants”) and (ii) one Warrant. Each Unit was sold to the
public at a price of $2.00 per Unit and each Pre-Funded Unit was sold to the public at a price of $1.999 per Pre-Funded Unit (which represents
the public offering price of each Unit less the $0.0001 per share nominal exercise price for each Pre-Funded Warrant). The Units;
the Pre-Funded Units; the shares of Common Stock comprising the Units; the Warrants; the Pre-Funded Warrants; the shares of Common
Stock, the Warrants and the Pre-Funded Warrants issuable upon exercise of the Over-Allotment Option; and the shares of Common Stock issuable
upon exercise of the Warrants and the Pre-Funded Warrants are collectively referred to herein as the “ Securities.”

On August 8, 2025, the Warrants commenced trading on The Nasdaq Capital
Market under the symbol “ BIVIW.” Each Warrant is immediately exercisable, entitles the holder to purchase one share of Common
Stock at an exercise price of $2.50 per share and expires five years from the date of issuance. Each Pre-Funded Warrant is immediately
exercisable, entitles the holder to purchase one share of Common Stock and may be